SCHEMBL7801436

SCHEMBL7801436

COc1ccc(CC(N)CC2CCNCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.52
SLC6A4 P31645 1/20 0.49
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KDM1A O60341 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
LDHA P00338 1/20 0.40
DPP4 P27487 1/20 0.39
FAP Q12884 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11402512 0.83 TDP1 (0.52) TDP1SLC6A4CYP2D6ALDH1A1SMN1; SMN2
SCHEMBL9264658 0.80 GBA1 (0.56) SLC6A4MAOA
SCHEMBL3155613 0.77 TDP1 (0.63) TDP1SLC6A4ALDH1A1SMN1; SMN2
SCHEMBL11358196 0.76 TDP1 (0.50) TDP1SLC6A4CYP1A2CYP2D6CYP2C19
SCHEMBL656814 0.76 SLC6A4 (0.73) SLC6A4CYP1A2CYP2D6CYP2C19LDHA
Bromide SCHEMBL7254135 0.75 TDP1 (0.61) TDP1SLC6A4ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL4778145 0.75 TDP1 (0.66) TDP1SLC6A4ALDH1A1SMN1; SMN2
SCHEMBL4251977 0.74 TDP1 (0.59) TDP1ALDH1A1SMN1; SMN2MAOBITGB3
SCHEMBL27175248 0.72 TAAR1 (0.62) SLC6A4ALDH1A1
SCHEMBL27175245 0.72 TAAR1 (0.62) SLC6A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0673927-B1 piperidines as anticholinergic agents EISAI CO LTD (JP) 2001-09-19 EP disclosed
EP-1116716-A1 Piperidine and piperazine compounds for use in the treatment of Alzheimer Eisai Co., Ltd. (JP) 2001-07-18 EP disclosed
EP-0742207-A1 2-(Indan-1-one-2-yl-alkyl)-1-phenylalkyl-piperidines and processes for their preparation Eisai Co., Ltd. (JP) 1996-11-13 EP disclosed
EP-0673927-A1 4-[2-indanyl-1-one]alkylpiperidines as anticholinergic agents Eisai Co., Ltd. (JP) 1995-09-27 EP disclosed
EP-0579263-A1 1,4-Substituted piperidines as acetylchozinesterase inhibitors and their use for the treatment of Alzheimer's disease Eisai Co., Ltd. (JP) 1994-01-19 EP disclosed
US-5100901-A Treatment of Alzheimer*s disease EISAI CO., LTD. (JP) 1992-03-31 US disclosed
US-4895841-A Cyclic amine compounds with activity against acetylcholinesterase EISAI CO., LTD. (JP) 1990-01-23 US disclosed
EP-0296560-A2 1,4-Substituted piperidines as acetylcholinesterase inhibitors and their use for the treatment of Alzheimer's disease Eisai Co., Ltd. (JP) 1988-12-28 EP disclosed